Value Aligned Research Advisors’s Legence Corp LGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.4M Buy
308,141
+56,460
+22% +$2.85M 0.08% 73
2025
Q4
$10.8M Buy
251,681
+46,427
+23% +$1.84M 0.11% 66
2025
Q3
$6.32M Buy
+205,254
New +$6.46M 0.08% 66

Other funds holding LGN

Value Aligned Research Advisors's LGN Position: Q1 2026 in Review

Value Aligned Research Advisors increased its Legence Corp (LGN) stake by 22% in Q1 2026, buying an estimated $2.85M and bringing the position to 308,141 shares worth $17.4M. The position accounts for 0.08% of the portfolio, ranked #73.

Value Aligned Research Advisors first reported a position in LGN in Q3 2025 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold LGN as of Q1 2026.

  • Value Aligned Research Advisors held 308,141 shares of Legence Corp worth $17.4M as of Q1 2026.
  • Value Aligned Research Advisors bought 56,460 Legence Corp shares in Q1 2026, an estimated $2.85M.
  • Legence Corp made up 0.08% of Value Aligned Research Advisors's portfolio in Q1 2026, its #73 holding.
  • Value Aligned Research Advisors first reported a position in Legence Corp in Q3 2025 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Legence Corp as of Q1 2026.

Based on Value Aligned Research Advisors's 13F filing for Q1 2026, filed 18 May 2026.